tetano
Editor, Senior Moderator
Am J Public Health
. 2020 Dec 22;e1-e5.
doi: 10.2105/AJPH.2020.306047. Online ahead of print.
Preparing for SARS-CoV-2 Vaccines in US Immigrant Communities: Strategies for Allocation, Distribution, and Communication
Eva H Clark[SUP] 1 [/SUP], Karla Fredricks[SUP] 1 [/SUP], Laila Woc-Colburn[SUP] 1 [/SUP], Maria Elena Bottazzi[SUP] 1 [/SUP], Jill Weatherhead[SUP] 1 [/SUP]
Affiliations
Abstract
Widely administered efficacious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are the safest and most efficient way to achieve individual- and population-level immunity, making SARS-CoV-2 vaccination the most viable strategy for controlling the coronavirus disease 2019 (COVID-19) pandemic in the United States. To this end, the US government has invested more than $10 billion in "Operation Warp Speed," a public-private partnership including the Centers for Disease Control and Prevention (CDC), the US Food and Drug Administration (FDA), and the US Department of Defense. Operation Warp Speed funded the development of several SARS-CoV-2 vaccines and aimed to deliver 300 million doses of a vaccine by the ambitious date of January 2021. (Am J Public Health. Published online ahead of print December 22, 2020: e1-e5. https://doi.org/10.2105/AJPH.2020.306047).
. 2020 Dec 22;e1-e5.
doi: 10.2105/AJPH.2020.306047. Online ahead of print.
Preparing for SARS-CoV-2 Vaccines in US Immigrant Communities: Strategies for Allocation, Distribution, and Communication
Eva H Clark[SUP] 1 [/SUP], Karla Fredricks[SUP] 1 [/SUP], Laila Woc-Colburn[SUP] 1 [/SUP], Maria Elena Bottazzi[SUP] 1 [/SUP], Jill Weatherhead[SUP] 1 [/SUP]
Affiliations
- PMID: 33351664
- DOI: 10.2105/AJPH.2020.306047
Abstract
Widely administered efficacious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are the safest and most efficient way to achieve individual- and population-level immunity, making SARS-CoV-2 vaccination the most viable strategy for controlling the coronavirus disease 2019 (COVID-19) pandemic in the United States. To this end, the US government has invested more than $10 billion in "Operation Warp Speed," a public-private partnership including the Centers for Disease Control and Prevention (CDC), the US Food and Drug Administration (FDA), and the US Department of Defense. Operation Warp Speed funded the development of several SARS-CoV-2 vaccines and aimed to deliver 300 million doses of a vaccine by the ambitious date of January 2021. (Am J Public Health. Published online ahead of print December 22, 2020: e1-e5. https://doi.org/10.2105/AJPH.2020.306047).